Jian Li

26PUBLICATIONS
101CO-AUTHORS
Molecular targetsChemotherapyEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Oct 05, 2026
Extracellular vesicle proteins monitor and interfere with CLDN18.2-targeted CAR-T cell and antibody therapies against gastrointestinal cancers.

|Aug 24, 2026
EMB-01, an Anti-EGFR/c-MET Bispecific Antibody, in Patients with Heavily Pretreated Metastatic Colorectal Cancer From a Phase Ib/II, Open-Label, Multicenter Study.

|Mar 21, 2026
Ultra-precision deconvolution of spatial transcriptomics decodes immune heterogeneity and fate-defining programs in tissues.

Yin Xu, Zurui Huang, Yawei Zhang

|Mar 04, 2026
Allogeneic B7-H3-Targeted CAR Vδ1T-cell Therapy in Advanced Solid Tumors: A Phase I Study.

Chang Liu, Jiarui Li, Dan Liu

|Dec 09, 2025
Long-term outcomes of ripretinib versus sunitinib in Chinese patients with advanced gastrointestinal stromal tumor: An updated analysis of a phase 2 randomized clinical trial.

Jun Zhang, Yanqiao Zhang, Haibo Qiu

|Dec 09, 2025
Disparities in management guidelines for gastrointestinal stromal tumors: A comparison of recommendations from the Chinese Society of Clinical Oncology, National Comprehensive Cancer Network, and European Society for Medical Oncology.

Zhidong Gao, Jian Li, Chao Wang

Pageof 5

Frequent Collaborators

13 joint publications

Lin Shen

7 joint publications

Lin Shen

5 joint publications

Changsong Qi

4 joint publications

Chang Liu